Target intelligence / Profile preview

B-cell receptor (BCR) recognizing influenza hemagglutinin and neuraminidase epitopes (BCR)

Target
BCR
Molecular classification
Receptor, Immunoglobulin family, Glycoprotein complex
01

Overview

The B-cell receptor (BCR) recognizing influenza hemagglutinin (HA) and neuraminidase (NA) epitopes is a specialized membrane-bound immunoglobulin complex essential for the adaptive immune response to influenza viruses [Lin et al., 2023, Nature]. These receptors, found on the surface of B lymphocytes, mediate the recognition of viral surface glycoproteins, specifically the hemagglutinin (HA) responsible for cell entry and the neuraminidase (NA) responsible for viral release [Wilson & Andrews, 2012, Nature Reviews Immunology]. A unique subset of these BCRs has been identified that can recognize conserved epitopes on both HA and NA, offering a promising target for the development of universal influenza vaccines that provide broad protection across different viral strains [Lin et al., 2023, Nature]. When these receptors bind to their respective viral epitopes, they trigger an intracellular signaling cascade involving key proteins such as Bruton's tyrosine kinase (BTK) and Syk, leading to B-cell activation, clonal expansion, and the production of neutralizing antibodies [Dal Porto et al., 2004, Molecular Immunology]. In drug development, these BCRs are the primary targets of vaccination strategies, which aim to elicit a robust and diverse antibody repertoire [Krammer, 2020, Nature Reviews Immunology]. Additionally, the signaling pathways downstream of the BCR are targets for small-molecule inhibitors like ibrutinib, which are used to treat B-cell related malignancies and are studied in the context of immune modulation [PubChem].

Other names
B-cell antigen receptorSurface immunoglobulinsIgHA/NA-specific B-cell receptorDual-specific B-cell receptor
02

Mechanism of action

Antigen binding to the BCR triggers receptor clustering and activation of intracellular signaling pathways, including the phosphorylation of ITAMs by Lyn and subsequent activation of Syk and BTK, leading to B-cell proliferation and differentiation [Dal Porto et al., 2004, Molecular Immunology].

03

Biological functions

Immune responseAntigen recognitionB-cell activationSignal transductionClonal expansion
04

Disease associations

InfectionInflammationAutoimmunity
05

Safety considerations

Original antigenic sinAntibody-dependent enhancement (ADE)Potential for cross-reactivity with self-antigensViral escape through antigenic drift
06

Interacting drugs

Influenza virus vaccine

3 more in the full profile.

07

Biomarkers

HA-specific B-cell frequencyNA-specific B-cell frequencyAnti-hemagglutinin antibody titersAnti-neuraminidase antibody titersBCR repertoire diversity

Beyond the preview

Go deeper on B-cell receptor (BCR) recognizing influenza hemagglutinin and neuraminidase epitopes (BCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell receptor (BCR) recognizing influenza hemagglutinin and neuraminidase epitopes (BCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call